Comment on "Durvalumab After Sequential Chemoradiotherapy in Stage III, Unresectable NSCLC: The Phase 2 PACIFIC-6 Trial".

Authors :: Yu S
Feng J
Source :: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2024 Jan; Vol. 19 (1), pp. 173-174.
Publication Year :: 2024

Language :: English
ISSN :: 1556-1380
Volume :: 19
Issue :: 1
Database :: MEDLINE
Journal :: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Publication Type :: Report
Accession number :: 38185511
Full Text :: https://doi.org/10.1016/j.jtho.2023.08.013

Full Text Access

Tools